HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of patients with complete and partial biotinidase deficiency: biochemical studies.

Abstract
Seventeen partially biotinidase-deficient patients detected by neonatal screening or family studies were compared with four patients with classical biotinidase deficiency. Using a sensitive HPLC method for biotinidase in plasma (substrate: biocytin) the patients could be divided into two groups: one with residual biotinidase activity, and the second with undetectable biotinidase activity (0-activity). Biocytin excretion, characteristically elevated in 0-activity patients, decreased rapidly with increasing residual biotinidase activity and was almost normal when residual activity exceeded 2-3% of mean normal. In one patient with classical disease (0-activity) biotin deficiency, typical organic aciduria and multiple carboxylase deficiency were found as early as at the second week of life. In contrast, 13 infants with residual activities from 1.2% to 23% had no remarkable clinical or biochemical abnormalities. However, in three 5-, 14- and 15-year-old healthy siblings with residual biotinidase activities between 2.3% and 4.2%, biotin deficiency was proven by decreased activities of the mitochondrial carboxylases in lymphocytes (30-57% of mean normal) and, in the older siblings, also by subnormal plasma biotin concentrations. In biotinidase deficiency, biotin depletion presumably occurs earlier in the brain than in other tissues and may thus first affect the central nervous system. For this reason and because of discrete biochemical abnormalities found in a patient with residual biotinidase activity of 8%, we suggest that at least all patients with residual activities below 10% should be treated with biotin.
AuthorsT M Suormala, E R Baumgartner, H Wick, S Scheibenreiter, S Schweitzer
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 13 Issue 1 Pg. 76-92 ( 1990) ISSN: 0141-8955 [Print] United States
PMID2109151 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acids
  • Fatty Acids
  • Biotin
  • Amidohydrolases
  • Biotinidase
  • biocytin
  • Lysine
Topics
  • Acids (metabolism)
  • Adolescent
  • Adult
  • Amidohydrolases (blood, deficiency)
  • Biotin (blood, therapeutic use, urine)
  • Biotinidase
  • Child, Preschool
  • Fatty Acids (metabolism)
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Lymphocytes (enzymology)
  • Lysine (analogs & derivatives, blood, urine)
  • Male
  • Metabolism, Inborn Errors (drug therapy, metabolism)
  • Multiple Carboxylase Deficiency (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: